Siemens Healthineers AG (Frankfurt: SHL) and Varian Medical Systems, Inc. (NYSE: VAR) announced that they have entered into an agreement, pursuant to which Siemens Healthineers shall acquire all shares of Varian for USD 177.50 per share in cash. This corresponds to a purchase price of approximately USD 16.4 billion.
Siemens Healthineers AG has also announced its results for the third quarter of fiscal year 2020 that ended June 30, 2020.
Documents
- Siemens Healthineers plans to acquire Varian to advance fight against cancer and strengthen its position in healthcare
- Siemens Healthineers shows resilient performance despite COVID-19 pandemic
- Journalist Presentation by Bernd Montag and Jochen Schmitz (German) (pdf) 2.39 MB
- Analyst Presentation by Bernd Montag and Jochen Schmitz (pdf) 2.46 MB
- Download quarterly statement (pdf) 0.18 MB
Management
Ralf P. Thomas
Chief Financial Officer and Member of the Managing Board of Siemens AG
Chairman of the Supervisory Board of Siemens Healthineers AG
Bernd Montag
Chief Executive Officer, Siemens Healthineers
Jochen Schmitz
Chief Financial Officer, Siemens Healthineers
Christoph Zindel
Member of the Managing Board, Siemens Healthineers
Further information
- Press feature Q2 FY2020
- Press feature Q1 FY2020
- Press feature Q4 FY2019 and fiscal year 2019
- More information on Varian
- Imaging for Radiation Therapy
- Siemens Healthineers-Varian Strategic Partnership – EnVision
- Customer story on the combined use of Siemens Healthineers and Varian equipment in Russia
- Customer story on the combined use of Siemens Healthineers and Varian equipment in Australia